• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 11/1/24: Navigating Diversity and Digital Innovation, Key Clinical Information on Infertility & more

News
Article

The latest news for pharma industry insiders.

Navigating Diversity and Digital Innovation at the Site-Level

In this video interview, Jimmy Bechtel, vice president, site engagement, SCRS, discusses some key initiatives around decentralized capabilities and underrepresented patient populations.

Key Clinical Information on Infertility

Lucy van de Wiel, PhD, discusses how infertility is defined as the inability to conceive after 12 months of regular unprotected intercourse, diagnosed through medical history, physical exams and tests, with risk factors including age, lifestyle habits and medical conditions.

Science Is Finding Ways to Regenerate Your Heart

Tissue-engineering techniques are in the works to regrow heart muscle after a heart attack and repair lungs and other organs.

Walgreens Offers No-Cost Rapid COVID-19 and Flu Testing to Military Veterans

To help improve access to fast, reliable testing for veterans, Walgreens is now offering no-cost testing through a partnership with the Centers for Disease Control and Prevention (CDC).* Eligible veterans will be able to receive an easy combination test for COVID-19 and influenza at Walgreens locations across the country throughout this year’s respiratory season, with results in 30 minutes or less.**

No-cost COVID-19 and flu testing will also continue to be available at Walgreens for uninsured patients via the CDC program.

Sam White on LinkedIn

I'm glad Pharmaceutical Executive invited me to publish this important topic of taking easy steps to start making an impact on sustainability. This will be even more important when public companies start collecting emissions data in 2025 for SEC reporting in 2026. The narrative of actions being taken will be just as important as the emissions data and GreenLabs Recycling is happy to support their efforts.

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs